| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2114881 | F | PubChem BioAssay. Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens. (Class of assay: confirmatory) | Homo sapiens | 2,057 | ALA1201862 | assay format | PubChem BioAssays | |
| 2. | ALA2114736 | F | PubChem BioAssay. Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Counter Screen Coupled Enzyme. (Class of assay: confirmatory) | 1,364 | ALA1201862 | assay format | PubChem BioAssays | ||
| 3. | ALA2114916 | F | PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) | Trypanosoma brucei | 6,592 | ALA1201862 | assay format | PubChem BioAssays | |
| 4. | ALA2354221 | F | PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) | 172,532 | ALA1201862 | assay format | PubChem BioAssays | ||
| 5. | ALA3215046 | F | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen. (Class of assay: confirmatory) | 9,563 | ALA1201862 | assay format | PubChem BioAssays | ||
| 6. | ALA3215069 | B | PubChem BioAssay. Counterscreen for inhibitors of the HGIII-SPLA2: QFRET-based biochemical high throughput dose response assay to identify inhibitors that optically interfere with 535nm fluorescence. (Class of assay: confirmatory) | 240 | ALA1201862 | assay format | PubChem BioAssays | ||
| 7. | ALA3215072 | B | PubChem BioAssay. QFRET-based biochemical high throughput dose response assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2). (Class of assay: confirmatory) | 240 | ALA1201862 | assay format | PubChem BioAssays | ||
| 8. | ALA3215181 | F | PubChem BioAssay. qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen. (Class of assay: confirmatory) | 36,517 | ALA1201862 | assay format | PubChem BioAssays | ||
| 9. | ALA3215278 | F | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | 23,091 | ALA1201862 | assay format | PubChem BioAssays | ||
| 10. | ALA3562077 | F | PubChem BioAssay. High Throughput Screening for Foot and Mouth Disease Virus Antivirals. (Class of assay: confirmatory) | 69,295 | ALA1201862 | assay format | PubChem BioAssays |
The page will load shortly, Thanks for your patience!